Exercise, but not antioxidants, reversed ApoE4-associated motor impairments in adult GFAP-ApoE mice

Behavioural Brain Research

Volumn 305, Issue , 2016, Pages 37-45

  Chaudhari, Kiran ^a   Wong, Jessica M ^a   Vann, Philip H ^a   Sumien, Nathalie ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Antioxidant; ApoE; Balance; Exercise; Motor function; Reflexes; Strength; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ASCORBIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY EQUILIBRIUM; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXERCISE; FEMALE; MALE; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; MUSCLE REFLEX; MUSCLE STRENGTH; NONHUMAN; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; ANIMAL; BODY WEIGHT; DISEASE MODEL; DRUG EFFECTS; EATING; GENETICS; HUMAN; KINESIOTHERAPY; LOCOMOTION; METABOLISM; MOVEMENT DISORDERS; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; REACTION TIME; REFLEX; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; APOLIPOPROTEIN E4; BODY WEIGHT; DISEASE MODELS, ANIMAL; EATING; EXERCISE THERAPY; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; LOCOMOTION; MICE; MICE, TRANSGENIC; MOVEMENT DISORDERS; MUSCLE, SKELETAL; PSYCHOMOTOR PERFORMANCE; REACTION TIME; REFLEX;

EID: 84978540255     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2016.02.014     Document Type: Article

References (79)

1. [1] Baddeley, A.D., Bressi, S., Della Sala, S., Logie, R., Spinnler, H., The decline of working memory in Alzheimer's disease. A longitudinal study. Brain 114:December (Pt. 6) (1991), 2521–2542.
2. [2] Kornecook, T.J., McKinney, A.P., Ferguson, M.T., Dodart, J.C., Isoform-specific effects of apolipoprotein E on cognitive performance in targeted-replacement mice overexpressing human APP. Genes Brain Behav. 9:March (2) (2010), 182–192.
3. [3] Stopford, C.L., Thompson, J.C., Neary, D., Richardson, A.M., Snowden, J.S., Working memory, attention, and executive function in Alzheimer's disease and frontotemporal dementia. Cortex 48:April (4) (2012), 429–446.
4. [4] Buchman, A.S., Bennett, D.A., Loss of motor function in preclinical Alzheimer's disease. Expert Rev. Neurother. 11:May (5) (2011), 665–676.
5. [5] Hebert, L.E., Bienias, J.L., McCann, J.J., Scherr, P.A., Wilson, R.S., Evans, D.A., Upper and lower extremity motor performance and functional impairment in Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen. 25:August (5) (2010), 425–431.
6. [6] Derouesne, C., Lagha-Pierucci, S., Thibault, S., Baudouin-Madec, V., Lacomblez, L., Apraxic disturbances in patients with mild to moderate Alzheimer's disease. Neuropsychologia 38:13 (2000), 1760–1769.
7. [7] Della Sala, S., Spinnler, H., Venneri, A., Walking difficulties in patients with Alzheimer's disease might originate from gait apraxia. J. Neurol. Neurosurg. Psychiatry 75:February (2) (2004), 196–201.
8. [8] Fogassi, L., Luppino, G., Motor functions of the parietal lobe. Curr. Opin. Neurobiol. 15:December (6) (2005), 626–631.
9. [9] Halsband, U., Lange, R.K., Motor learning in man: a review of functional and clinical studies. J. Physiol. Paris 99:June 4–6 (2006), 414–424.
10. [10] Jeannerod, M., Arbib, M.A., Rizzolatti, G., Sakata, H., Grasping objects: the cortical mechanisms of visuomotor transformation. Trends Neurosci. 18:July (7) (1995), 314–320.
11. [11] Lehericy, S., Bardinet, E., Tremblay, L., Van de Moortele, P.F., Pochon, J.B., Dormont, D., et al. Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cereb. Cortex 16:February (2) (2006), 149–161.
12. [12] Gearing, M., Levey, A.I., Mirra, S.S., Diffuse plaques in the striatum in Alzheimer disease (AD): relationship to the striatal mosaic and selected neuropeptide markers. J. Neuropathol. Exp. Neurol. 56:December (12) (1997), 1363–1370.
13. [13] Horoupian, D.S., Wasserstein, P.H., Alzheimer's disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration. Acta Neuropathol. 98:September (3) (1999), 317–322.
14. [14] Schneider, J.A., Li, J.L., Li, Y., Wilson, R.S., Kordower, J.H., Bennett, D.A., Substantia nigra tangles are related to gait impairment in older persons. Ann. Neurol. 59:January (1) (2006), 166–173.
15. [15] Larner, A.J., The cerebellum in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 8:July–August (4) (1997), 203–209.
16. [16] Mavroudis, I.A., Fotiou, D.F., Adipepe, L.F., Manani, M.G., Njau, S.D., Psaroulis, D., et al. Morphological changes of the human purkinje cells and deposition of neuritic plaques and neurofibrillary tangles on the cerebellar cortex of Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen. 25:November (7) (2010), 585–591.
17. [17] Guerrero-Berroa, E., Ravona-Springer, R., Heymann, A., Schmeidler, J., Silverman, J.M., Sano, M., et al. Decreased motor function is associated with poorer cognitive function in elderly with type 2 diabetes. Dement. Geriatr. Cogn. Dis. Extra 4:April (1) (2014), 103–112.
18. [18] Blacker, D., Haines, J.L., Rodes, L., Terwedow, H., Go, R.C., Harrell, L.E., et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology 48:January (1) (1997), 139–147.
19. [19] Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90:March (5) (1993), 1977–1981.
20. [20] Maestre, G., Ottman, R., Stern, Y., Gurland, B., Chun, M., Tang, M.X., et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann. Neurol. 37:February (2) (1995), 254–259.
21. [21] Alzheimer's Association, Alzheimer's disease facts and figures. Alzheimers Dement. 8:2 (2012), 131–168.
22. [22] Buchman, A.S., Boyle, P.A., Wilson, R.S., Beck, T.L., Kelly, J.F., Bennett, D.A., Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons. Alzheimer Dis. Assoc. Disord. 23:January–March (1) (2009), 63–69.
23. [23] Grootendorst, J., Bour, A., Vogel, E., Kelche, C., Sullivan, P.M., Dodart, J.C., et al. Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior. Behav. Brain Res. 159:April (1) (2005), 1–14.
24. [24] Raber, J., Wong, D., Buttini, M., Orth, M., Bellosta, S., Pitas, R.E., et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. Natl. Acad. Sci. U. S. A. 95:September (18) (1998), 10914–10919.
25. [25] Hartman, R.E., Wozniak, D.F., Nardi, A., Olney, J.W., Sartorius, L., Holtzman, D.M., Behavioral phenotyping of GFAP-apoE3 and −apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp. Neurol. 170:August (2) (2001), 326–344.
26. [26] Boyles, J.K., Pitas, R.E., Wilson, E., Mahley, R.W., Taylor, J.M., Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76:October (4) (1985), 1501–1513.
27. [27] Xu, P.T., Gilbert, J.R., Qiu, H.L., Ervin, J., Rothrock-Christian, T.R., Hulette, C., et al. Specific regional transcription of apolipoprotein E in human brain neurons. Am. J. Pathol. 154:February (2) (1999), 601–611.
28. [28] Slooter, A.J., Cruts, M., Kalmijn, S., Hofman, A., Breteler, M.M., Van Broeckhoven, C., et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch. Neurol. 55:July (7) (1998), 964–968.
29. [29] Small, G.W., Komo, S., La Rue, A., Saxena, S., Phelps, M.E., Mazziotta, J.C., et al. Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging. Ann. N. Y. Acad. Sci. 802:December (16) (1996), 70–78.
30. [30] Scarmeas, N., Luchsinger, J.A., Schupf, N., Brickman, A.M., Cosentino, S., Tang, M.X., et al. Physical activity, diet, and risk of Alzheimer disease. JAMA 302:August (6) (2009), 627–637.
31. [31] Larson, E.B., Wang, L., Bowen, J.D., McCormick, W.C., Teri, L., Crane, P., et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 144:January (2) (2006), 73–81.
32. [32] Buchman, A.S., Boyle, P.A., Yu, L., Shah, R.C., Wilson, R.S., Bennett, D.A., Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology 78:April (17) (2012), 1323–1329.
33. [33] Liu-Ambrose, T., Nagamatsu, L.S., Graf, P., Beattie, B.L., Ashe, M.C., Handy, T.C., Resistance training and executive functions: a 12-month randomized controlled trial. Arch. Intern. Med. 170:January (2) (2010), 170–178.
34. [34] Bugg, J.M., Head, D., Exercise moderates age-related atrophy of the medial temporal lobe. Neurobiol. Aging 32:March (3) (2011), 506–514.
35. [35] Head, D., Bugg, J.M., Goate, A.M., Fagan, A.M., Mintun, M.A., Benzinger, T., et al. Exercise engagement as a moderator of the effects of APOE genotype on amyloid deposition. Arch. Neurol. 69:May (5) (2012), 636–643.
36. [36] Brown, B.M., Peiffer, J.J., Martins, R.N., Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease?. Mol. Psychiatry, 18(November (20)), 2013.
37. [37] Schwenk, M., Dutzi, I., Englert, S., Micol, W., Najafi, B., Mohler, J., et al. An intensive exercise program improves motor performances in patients with dementia: translational model of geriatric rehabilitation. J. Alzheimers Dis. 39:3 (2013), 487–498.
38. [38] Hauer, K., Schwenk, M., Zieschang, T., Essig, M., Becker, C., Oster, P., Physical training improves motor performance in people with dementia: a randomized controlled trial. J. Am. Geriatr. Soc. 60:January (1) (2012), 8–15.
39. [39] Zieschang, T., Schwenk, M., Oster, P., Hauer, K., Sustainability of motor training effects in older people with dementia. J. Alzheimers Dis. 34:January (1) (2013), 191–202.
40. [40] Hauer, K., Rost, B., Rutschle, K., Opitz, H., Specht, N., Bartsch, P., et al. Exercise training for rehabilitation and secondary prevention of falls in geriatric patients with a history of injurious falls. J. Am. Geriatr. Soc. 49:January (1) (2001), 10–20.
41. [41] Hauer, K., Pfisterer, M., Schuler, M., Bartsch, P., Oster, P., Two years later: a prospective long-term follow-up of a training intervention in geriatric patients with a history of severe falls. Arch. Phys. Med. Rehabil. 84:October (10) (2003), 1426–1432.
42. [42] Faber, M.J., Bosscher, R.J., Chin, A., Paw, M.J., van Wieringen, P.C., Effects of exercise programs on falls and mobility in frail and pre-frail older adults: a multicenter randomized controlled trial. Arch. Phys. Med. Rehabil. 87:July (7) (2006), 885–896.
43. [43] Pratico, D., Sung, S., Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J. Alzheimers Dis. 6:April (2) (2004), 171–175.
44. [44] Markesbery, W.R., Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1 (1997), 134–147.
45. [45] Tayler, H., Fraser, T., Miners, J.S., Kehoe, P.G., Love, S., Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-beta. J. Alzheimers Dis. 22:4 (2010), 1363–1373.
46. [46] Zito, G., Polimanti, R., Panetta, V., Ventriglia, M., Salustri, C., Siotto, M., et al. Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia. Rejuvenation Res.(December (6)), 2012.
47. [47] Sano, M., Ernesto, C., Thomas, R.G., Klauber, M.R., Schafer, K., Grundman, M., et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. Alzheimer's Dis. Cooperative Study. N. Engl. J. Med. 336:April (17) (1997), 1216–1222.
48. [48] Fotuhi, M., Zandi, P.P., Hayden, K.M., Khachaturian, A.S., Szekely, C.A., Wengreen, H., et al. Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache county study. Alzheimers Dement. 4:May (3) (2008), 223–227.
49. [49] Yasuno, F., Tanimukai, S., Sasaki, M., Ikejima, C., Yamashita, F., Kodama, C., et al. Combination of antioxidant supplements improved cognitive function in the elderly. J. Alzheimers Dis. 32:4 (2012), 895–903.
50. [50] Harrison, F.E., Bowman, G.L., Polidori, M.C., Ascorbic acid and the brain: rationale for the use against cognitive decline. Nutrients 6:April (4) (2014), 1752–1781.
51. [51] Majewicz, J., Rimbach, G., Proteggente, A.R., Lodge, J.K., Kraemer, K., Minihane, A.M., Dietary vitamin C down-regulates inflammatory gene expression in apoE4 smokers. Biochem. Biophys. Res. Commun. 338:December (2) (2005), 951–955.
52. [52] Joseph, J.A., Shukitt-Hale, B., Denisova, N.A., Bielinski, D., Martin, A., McEwen, J.J., et al. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J. Neurosci. 19:September (18) (1999), 8114–8121.
53. [53] Kontush, A., Mann, U., Arlt, S., Ujeyl, A., Luhrs, C., Muller-Thomsen, T., et al. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. Free Radic. Biol. Med. 31:August (3) (2001), 345–354.
54. [54] Niki, E., Interaction of ascorbate and alpha-tocopherol. Ann. N. Y. Acad. Sci. 498 (1987), 186–199.
55. [55] Bouzid, M.A., Hammouda, O., Matran, R., Robin, S., Fabre, C., Low intensity aerobic exercise and oxidative stress markers in older adults. J. Aging Phys. Act.(November (13)), 2013.
56. [56] Allgayer, H., Owen, R.W., Nair, J., Spiegelhalder, B., Streit, J., Reichel, C., et al. Short-term moderate exercise programs reduce oxidative DNA damage as determined by high-performance liquid chromatography-electrospray ionization-mass spectrometry in patients with colorectal carcinoma following primary treatment. Scand. J. Gastroenterol. 43:August (8) (2008), 971–978.
57. [57] Herring, A., Blome, M., Ambree, O., Sachser, N., Paulus, W., Keyvani, K., Reduction of cerebral oxidative stress following environmental enrichment in mice with Alzheimer-like pathology. Brain Pathol. 20:January (1) (2010), 166–175.
58. [58] Radak, Z., Hart, N., Sarga, L., Koltai, E., Atalay, M., Ohno, H., et al. Exercise plays a preventive role against Alzheimer's disease. J. Alzheimers Dis. 20:3 (2010), 777–783.
59. [59] Cetin, E., Top, E.C., Sahin, G., Ozkaya, Y.G., Aydin, H., Toraman, F., Effect of vitamin E supplementation with exercise on cognitive functions and total antioxidant capacity in older people. J. Nutr. Health Aging 14:November (9) (2010), 763–769.
60. [60] Devi, S.A., Kiran, T.R., Regional responses in antioxidant system to exercise training and dietary vitamin E in aging rat brain. Neurobiol. Aging 25:April (4) (2004), 501–508.
61. [61] Jolitha, A.B., Subramanyam, M.V., Asha Devi, S., Modification by vitamin E and exercise of oxidative stress in regions of aging rat brain: studies on superoxide dismutase isoenzymes and protein oxidation status. Exp. Gerontol. 41:August (8) (2006), 753–763.
62. [62] Wu, A., Ying, Z., Gomez-Pinilla, F., Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 155:August (3) (2008), 751–759.
63. [63] Chaudhari, K., Wong, J.M., Vann, P.H., Sumien, N., Exercise training and antioxidant supplementation independently improve cognitive function in adult male and female GFAP-APOE mice. J. Sport Health Sci. 3:3 (2014), 196–205.
64. [64] Su, S.H., Chen, H., Jen, C.J., C57BL/6 and BALB/c bronchoalveolar macrophages respond differently to exercise. J. Immunol. 167:November (9) (2001), 5084–5091.
65. [65] Forster, M.J., Lal, H., Neurobehavioral biomarkers of aging: influence of genotype and dietary restriction. Biomed. Environ. Sci. 4:June (1–2) (1991), 144–165.
66. [66] Forster, M.J., Lal, H., Estimating age-related changes in psychomotor function: influence of practice and of level of caloric intake in different genotypes. Neurobiol. Aging 20:March–April (2) (1999), 167–176.
67. [67] Siegel, J.A., Haley, G.E., Raber, J., Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice. Neurobiol. Aging 33:February (2) (2012), 345–358.
68. [68] van Meer, P., Acevedo, S., Raber, J., Impairments in spatial memory retention of GFAP-apoE4 female mice. Behav. Brain Res. 176:January (2) (2007), 372–375.
69. [69] Lima, L.O., Scianni, A., Rodrigues-de-Paula, F., Progressive resistance exercise improves strength and physical performance in people with mild to moderate Parkinson's disease: a systematic review. J. Physiother. 59:March (1) (2013), 7–13.
70. [70] Siciliano, G., Simoncini, C., Lo Gerfo, A., Orsucci, D., Ricci, G., Mancuso, M., Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies. Neuromuscul. Disord. 22:December Suppl. (3) (2012), S172–7.
71. [71] Sveen, M.L., Jeppesen, T.D., Hauerslev, S., Kober, L., Krag, T.O., Vissing, J., Endurance training improves fitness and strength in patients with Becker muscular dystrophy. Brain 131:November Pt. (11) (2008), 2824–2831.
72. [72] Sveen, M.L., Andersen, S.P., Ingelsrud, L.H., Blichter, S., Olsen, N.E., Jonck, S., et al. Resistance training in patients with limb-girdle and becker muscular dystrophies. Muscle Nerve 47:February (2) (2013), 163–169.
73. [73] Graber, T.G., Ferguson-Stegall, L., Liu, H., Thompson, L.V., Voluntary aerobic exercise reverses frailty in old mice. J. Gerontol. A. Biol. Sci. Med. Sci. 70:9 (2014), 1045–1058.
74. [74] Yun, H.S., Park, M.S., Ji, E.S., Kim, T.W., Ko, I.G., Kim, H.B., et al. Treadmill exercise ameliorates symptoms of attention deficit/hyperactivity disorder through reducing Purkinje cell loss and astrocytic reaction in spontaneous hypertensive rats. J. Exerc. Rehabil 10:February (1) (2014), 22–30.
75. [75] Shetty, R.A., Ikonne, U.S., Forster, M.J., Sumien, N., Coenzyme Q10 and alpha-tocopherol reversed age-associated functional impairments in mice. Exp. Gerontol. 58:October (2014), 208–218.
76. [76] Pitozzi, V., Jacomelli, M., Catelan, D., Servili, M., Taticchi, A., Biggeri, A., et al. Long-term dietary extra-virgin olive oil rich in polyphenols reverses age-related dysfunctions in motor coordination and contextual memory in mice: role of oxidative stress. Rejuvenation Res. 15:December (6) (2012), 601–612.
77. [77] Richwine, A.F., Godbout, J.P., Berg, B.M., Chen, J., Escobar, J., Millard, D.K., et al. Improved psychomotor performance in aged mice fed diet high in antioxidants is associated with reduced ex vivo brain interleukin-6 production. Brain Behav. Immun. 19:November (6) (2005), 512–520.
78. [78] Ristow, M., Zarse, K., Oberbach, A., Kloting, N., Birringer, M., Kiehntopf, M., et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. U. S. A. 106:May (21) (2009), 8665–8670.
79. [79] Wray, D.W., Uberoi, A., Lawrenson, L., Bailey, D.M., Richardson, R.S., Oral antioxidants and cardiovascular health in the exercise-trained and untrained elderly: a radically different outcome. Clin. Sci. (Lond.) 116:March (5) (2009), 433–441.